|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.27 USD | +4.21% |
|
+2.65% | +6.95% |
| 07-03 | Trial for Ebola treatment starts in DR Congo | RE |
| 07-02 | Trial for Bundibugyo Ebola treatment starts in DRC, WHO says | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +4.21% | +2.65% | +6.95% | +17.47% | +89.42% | 163B |  | | |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
